AR019485A1 - Una composicion farmaceutica y el metodo para producir y administrar la misma. - Google Patents

Una composicion farmaceutica y el metodo para producir y administrar la misma.

Info

Publication number
AR019485A1
AR019485A1 ARP990103691A ARP990103691A AR019485A1 AR 019485 A1 AR019485 A1 AR 019485A1 AR P990103691 A ARP990103691 A AR P990103691A AR P990103691 A ARP990103691 A AR P990103691A AR 019485 A1 AR019485 A1 AR 019485A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
drug
manage
produce
same
Prior art date
Application number
ARP990103691A
Other languages
English (en)
Spanish (es)
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR019485A1 publication Critical patent/AR019485A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ARP990103691A 1998-07-31 1999-07-27 Una composicion farmaceutica y el metodo para producir y administrar la misma. AR019485A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21751798 1998-07-31

Publications (1)

Publication Number Publication Date
AR019485A1 true AR019485A1 (es) 2002-02-20

Family

ID=16705487

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103691A AR019485A1 (es) 1998-07-31 1999-07-27 Una composicion farmaceutica y el metodo para producir y administrar la misma.

Country Status (10)

Country Link
EP (1) EP1100466A1 (ko)
KR (1) KR20010072151A (ko)
CN (1) CN1161106C (ko)
AR (1) AR019485A1 (ko)
AU (1) AU4802699A (ko)
BR (1) BR9912533A (ko)
CA (1) CA2338996A1 (ko)
HK (1) HK1040191A1 (ko)
ID (1) ID28910A (ko)
WO (1) WO2000006122A1 (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004535370A (ja) 2001-03-05 2004-11-25 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 味をマスクした液体製薬学的組成物
US6767557B2 (en) 2001-03-05 2004-07-27 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical compositions
ES2338009T3 (es) * 2003-07-11 2010-05-03 Astrazeneca Ab Composicion solida que comprende un inhibidor de la bomba de protones.
CN100435847C (zh) * 2004-05-13 2008-11-26 宝龄富锦生技股份有限公司 含有难溶解性主药之持续释放配方
EP1757268B1 (en) 2004-06-07 2017-07-05 Kureha Corporation Dry-form composition for oral ingestion and gel-form composition for oral ingestion of type prepared at time of use
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
RU2012147899A (ru) * 2010-05-24 2014-06-27 Америлаб Текнолоджиз, Инк. Шипучая композиция для формирования желатинизированной композиции, таблетка для формирования желатинизированной композиции и способ изготовления желатинизированной композиции
CA2847614C (en) 2011-09-30 2018-10-23 Mochida Pharmaceutical Co., Ltd. Easily dosable solid preparation
KR102555664B1 (ko) * 2017-02-21 2023-07-18 이에이 파마 가부시키가이샤 과립 제제
FR3101546B1 (fr) 2019-10-07 2023-11-10 Roquette Freres Masquage du goût de l’isosorbide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
ATE352289T1 (de) * 1995-05-02 2007-02-15 Taisho Pharmaceutical Co Ltd Mittel zur oralen verabreichung
DE69633925T2 (de) * 1995-07-21 2005-11-24 Daiichi Pharmaceutical Co., Ltd. Verfahren zur Herstellung einer granulären Zubereitung
CA2227314A1 (en) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives

Also Published As

Publication number Publication date
AU4802699A (en) 2000-02-21
CN1161106C (zh) 2004-08-11
CN1316899A (zh) 2001-10-10
EP1100466A1 (en) 2001-05-23
CA2338996A1 (en) 2000-02-10
ID28910A (id) 2001-07-12
WO2000006122A1 (en) 2000-02-10
KR20010072151A (ko) 2001-07-31
HK1040191A1 (zh) 2002-05-31
BR9912533A (pt) 2002-02-13

Similar Documents

Publication Publication Date Title
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR019485A1 (es) Una composicion farmaceutica y el metodo para producir y administrar la misma.
ES2411179T3 (es) Oblea de buprenorfina para la terapia de sustitución de drogas
AR054139A1 (es) Formulacion modificada y de liberacion inmediata de esferas de memantina
TR199700930T2 (xx) Ereksiyon bozuklu�unu �nlemek i�in y�ntem ve kit.
ECSP056159A (es) Composición de fármaco conjugado
AR033548A1 (es) Composicion farmaceutica que comprende un inhibidor de lipasa, un procedimiento para su preparacion, equipo transportable a modo de ''kit'', el uso de dicha composicion en la fabricacion de medicamentos, un inhibidor de lipasa y un secuestrante de acidos biliares
UY24246A1 (es) Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
WO2002032376A3 (en) Bile-acid conjugates for providing sustained systemic concentrations of drugs
ECSP003847A (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
CL2004000573A1 (es) Composicion farmaceutica que comprende un aceite anfipatico, cera microcristalina y un vehiculo no acuoso, donde dicho vehiculo tiene disperso un agente antiinflamatorio, y su uso para tratar y/o prevenir una afeccion inflamatoria en un organo que co
DE60220408D1 (de) Sequenzielles arzneimittelabgabesystem
DE602004026604D1 (de) Pharmazeutische kombinationen von hydrocodon und naltrexon
SG152257A1 (en) Topical preparation containing ambroxol
CA2324904A1 (fr) Composition hormonale topique a effet systemique
WO2006118948A3 (en) Therapeutic compositions
PT1267832E (pt) Sistema auto-emulsionante de libertacao de farmaco
BRPI0510259A (pt) formulação cosmética ou dermatológica transparente
RU2009120990A (ru) Применение тестостерона и агониста 5-нт1а для лечения сексуальной дисфункции
ATE445389T1 (de) Liposomale glucocorticoide
HUP0000137A2 (hu) Szabályozott hatóanyag-felszabadulású analgetikumot tartalmazó gyógyszerkészítmény
BRPI0506630A (pt) composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada
EA200702496A1 (ru) Местная композиция, содержащая желатин
WO2005065648A3 (en) Novel drug compositions and dosage forms of topiramate
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal